Answers are grounded in this paper and cite their sources.
INTRODUCTION: Opioid analgesics are given to critically ill neonates to reduce pain and stress during their stay in neonatal intensive care (NICU). However, there is limited data regarding neurodevelopmental (NDV) outcomes of newborns exposed to opioids, and available studies have had conflicting results.EVIDENCE ACQUISITION: We conducted a systematic review to explore the neurological outcomes of mechanically ventilated neonates who received opioids for sedation. Moreover, we investigated the effectiveness of opioids on level of sedation and on respiratory outcome. Data regarding opioids and neurological outcome, from the included studies, were collected.EVIDENCE SYNTHESIS: Twenty-eight studies (15 cohort studies and 13 randomized controlled trials [RCTs]) were included. Five RCTs and thirteen cohort studies investigated NDV using different NDV scales. Four RTCs and eight cohort studies found no significant difference in long term NDV for neonates exposed to opioids during early life. One RCTs and five cohort studies showed a negative correlation between opioids exposure and NDV. Most of the reviewed investigations showed prolonged mechanical ventilation in neonates who received opioids. However, nine RCTs and three cohort studies did not report any differences in terms of respiratory outcome. Inconclusive results were reported by investigations that assessed the effectiveness of level of sedation by different pain scores. Given the heterogeneity of the studies in terms of interventions and neurological assessments, a meta-analysis was not feasible.CONCLUSIONS: In conclusion, despite their limited efficacy on sedation, concerns regarding the safety of these drugs have arisen, therefore we would suggest caution of opioids use for managing pain in mechanically ventilated neonates.
No takes yet. Share an insight, caveat, or question.
Nardo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: